For research use only. Not for therapeutic Use.
Nizatidine(Cat No.:A000709)is a potent histamine H2 receptor antagonist used primarily to treat gastrointestinal conditions such as ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. By blocking H2 receptors in the stomach lining, it effectively reduces the production of gastric acid, helping to alleviate symptoms associated with acid reflux and promoting the healing of ulcers. Nizatidine is well-known for its rapid action and relatively favorable safety profile, making it a valuable therapeutic option in managing acid-related disorders in both clinical and research settings.
Catalog Number | A000709 |
CAS Number | 76963-41-2 |
Synonyms | 76963-41-2; Axid; Acinon; Zanizal; Nizax |
Molecular Formula | C12H21N5O2S2 |
Purity | ≥95% |
Target | Neuronal Signaling |
Solubility | Soluble in DMSO > 10 mM |
Storage | -20°C |
IUPAC Name | (E)-1-N'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine |
InChI | InChI=1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3/b11-6+ |
InChIKey | SGXXNSQHWDMGGP-IZZDOVSWSA-N |
SMILES | CN/C(=C\[N+](=O)[O-])/NCCSCC1=CSC(=N1)CN(C)C |
Reference | 1: Sanad MH, Saleh GM, Marzook FA. Radioiodination and biological evaluation of 2: Sailaja U, Shahin Thayyil M, Krishna Kumar NS, Govindaraj G, Ngai KL. 3: Viciosa MT, Moura Ramos JJ, Diogo HP. The Slow Relaxation Dynamics in the 4: Morrissey KM, Stocker SL, Chen EC, Castro RA, Brett CM, Giacomini KM. The 5: Shang DW, Wang ZZ, Ni XJ, Zhang M, Hu JQ, Qiu C, Wen YG. Development and 6: Sakakibara R, Doi H, Sato M, Hirai S, Masaka T, Kishi M, Tsuyusaki Y, Tateno <br> 8: Jain A, Pandey V, Ganeshpurkar A, Dubey N, Bansal D. Formulation and <br> <br> |